Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 37 studies | 41% ± 21% | |
| naive B cell | 20 studies | 44% ± 16% | |
| memory B cell | 17 studies | 30% ± 9% | |
| endothelial cell | 14 studies | 40% ± 21% | |
| macrophage | 14 studies | 30% ± 16% | |
| plasmacytoid dendritic cell | 14 studies | 36% ± 10% | |
| glutamatergic neuron | 13 studies | 76% ± 19% | |
| oligodendrocyte precursor cell | 12 studies | 42% ± 13% | |
| GABAergic neuron | 11 studies | 64% ± 25% | |
| fibroblast | 10 studies | 34% ± 15% | |
| smooth muscle cell | 10 studies | 36% ± 12% | |
| dendritic cell | 9 studies | 37% ± 19% | |
| neuron | 8 studies | 48% ± 26% | |
| astrocyte | 7 studies | 41% ± 19% | |
| interneuron | 7 studies | 69% ± 24% | |
| microglial cell | 7 studies | 47% ± 23% | |
| adipocyte | 7 studies | 36% ± 11% | |
| retinal ganglion cell | 6 studies | 52% ± 28% | |
| precursor B cell | 6 studies | 58% ± 20% | |
| immature B cell | 6 studies | 57% ± 9% | |
| retina horizontal cell | 6 studies | 57% ± 29% | |
| myeloid cell | 6 studies | 27% ± 8% | |
| type II pneumocyte | 6 studies | 64% ± 24% | |
| amacrine cell | 5 studies | 68% ± 25% | |
| oligodendrocyte | 5 studies | 37% ± 17% | |
| pericyte | 4 studies | 35% ± 20% | |
| granule cell | 4 studies | 78% ± 8% | |
| pro-B cell | 4 studies | 40% ± 7% | |
| cardiac muscle cell | 4 studies | 21% ± 4% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 35% ± 8% | |
| capillary endothelial cell | 4 studies | 50% ± 30% | |
| club cell | 4 studies | 35% ± 12% | |
| conventional dendritic cell | 3 studies | 43% ± 10% | |
| GABAergic interneuron | 3 studies | 72% ± 2% | |
| GABAergic amacrine cell | 3 studies | 80% ± 13% | |
| Mueller cell | 3 studies | 26% ± 5% | |
| OFF-bipolar cell | 3 studies | 22% ± 5% | |
| ON-bipolar cell | 3 studies | 41% ± 11% | |
| glycinergic amacrine cell | 3 studies | 71% ± 15% | |
| retinal pigment epithelial cell | 3 studies | 40% ± 16% | |
| innate lymphoid cell | 3 studies | 34% ± 15% | |
| ciliated cell | 3 studies | 17% ± 0% | |
| monocyte | 3 studies | 28% ± 5% | |
| group 3 innate lymphoid cell | 3 studies | 42% ± 6% | |
| melanocyte | 3 studies | 60% ± 33% | |
| abnormal cell | 3 studies | 39% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 3737.74 | 243 / 245 | 94% | 20.68 | 472 / 502 |
| brain | 97% | 2457.05 | 2559 / 2642 | 90% | 7.76 | 632 / 705 |
| breast | 84% | 2557.44 | 387 / 459 | 82% | 34.75 | 918 / 1118 |
| lung | 99% | 2301.99 | 573 / 578 | 18% | 0.85 | 209 / 1155 |
| uterus | 99% | 2280.90 | 168 / 170 | 15% | 1.68 | 71 / 459 |
| stomach | 98% | 1365.87 | 352 / 359 | 9% | 0.42 | 27 / 286 |
| ovary | 100% | 2270.71 | 180 / 180 | 7% | 0.38 | 30 / 430 |
| skin | 33% | 176.24 | 603 / 1809 | 73% | 7.13 | 345 / 472 |
| bladder | 100% | 2736.90 | 21 / 21 | 6% | 0.41 | 31 / 504 |
| adrenal gland | 57% | 368.68 | 148 / 258 | 47% | 2.96 | 109 / 230 |
| kidney | 47% | 370.01 | 42 / 89 | 57% | 3.40 | 517 / 901 |
| intestine | 97% | 1824.28 | 938 / 966 | 5% | 0.32 | 24 / 527 |
| spleen | 100% | 1875.27 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 1283.77 | 1281 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 16.43 | 27 / 29 |
| esophagus | 81% | 2004.15 | 1166 / 1445 | 7% | 0.35 | 12 / 183 |
| liver | 42% | 227.96 | 96 / 226 | 44% | 2.22 | 180 / 406 |
| adipose | 73% | 690.56 | 879 / 1204 | 0% | 0 | 0 / 0 |
| heart | 73% | 578.90 | 628 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 64% | 4.05 | 51 / 80 |
| thymus | 13% | 88.96 | 82 / 653 | 16% | 0.88 | 97 / 605 |
| peripheral blood | 22% | 148.32 | 207 / 929 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 1.80 | 1 / 328 | 15% | 0.70 | 26 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 0.34 | 6 / 45 |
| muscle | 10% | 53.58 | 83 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010468 | Biological process | regulation of gene expression |
| GO_0034612 | Biological process | response to tumor necrosis factor |
| GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0032783 | Cellular component | super elongation complex |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0003690 | Molecular function | double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| Gene name | AFF3 |
| Protein name | ALF transcription elongation factor 3 AF4/FMR2 family member 3 (Lymphoid nuclear protein related to AF4) (Protein LAF-4) Alternative protein AFF3 |
| Synonyms | LAF4 |
| Description | FUNCTION: Putative transcription activator that may function in lymphoid development and oncogenesis. Binds, in vitro, to double-stranded DNA. |
| Accessions | ENST00000445815.2 ENST00000430789.1 ENST00000415384.2 ENST00000672269.1 ENST00000409236.6 [P51826-1] ENST00000427118.1 A0A5F9ZHU9 P51826 ENST00000672204.1 L8E9Z7 C9J847 C9JIB1 C9JUY1 H7C3W3 ENST00000440445.6 A0A5F9ZHV2 ENST00000672197.1 ENST00000424600.5 C9JC67 ENST00000423966.6 ENST00000671937.1 C9JMS1 C9JZ66 ENST00000672857.1 ENST00000673232.1 ENST00000317233.8 [P51826-1] ENST00000441400.5 A0A5F9ZHE5 ENST00000673328.1 ENST00000672756.2 [P51826-1] A0A5F9ZHZ1 A0A5F9ZHV9 ENST00000416492.5 A0A5F9ZHH7 ENST00000409579.5 [P51826-2] C9JUC4 C9J622 H7C4C2 ENST00000432037.5 |